Antineoplastic Agents, Hormonal [hormonální protinádorové látky]
- Terms
-
antitumorózní látky hormonální
hormonální antineoplastické látky
hormonální protinádorová léčiva
-
Antineoplastic Drugs, Hormonal
Antineoplastic Hormonal Agents
Antineoplastic Hormonal Drugs
Antineoplastics, Hormonal
Hormonal Agents, Antineoplastic
Hormonal Antineoplastic Agents
Hormonal Antineoplastic Drugs
Hormonal Antineoplastics
Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079)
- Annotation
- consider also NEOPLASMS, HORMONE-DEPENDENT /drug ther
- DUI
- D018931 MeSH Browser
- CUI
- M0028300
- Previous indexing
- Antineoplastic Agents (1966-1995)
- History note
- 96
- Public note
- 96
Allowable subheadings
- AD
- administration & dosage 92
- AE
- adverse effects 87
- AG
- agonists 0
- AN
- analysis 0
- AI
- antagonists & inhibitors 0
- BL
- blood 1
- CF
- cerebrospinal fluid 0
- CS
- chemical synthesis 0
- CH
- chemistry 2
- CL
- classification 23
- EC
- economics 2
- HI
- history 2
- IM
- immunology 1
- IP
- isolation & purification 0
- ME
- metabolism 1
- PK
- pharmacokinetics 13
- PD
- pharmacology 77
- PO
- poisoning 0
- RE
- radiation effects 0
- ST
- standards 0
- SD
- supply & distribution 0
- TU
- therapeutic use 334
- TO
- toxicity 2
- UR
- urine 0